Skip to main content
Log in

Sinomenine derivatives with embedment of nitrogen-containing heterocycles exhibiting potent TNF-αinhibitory activity

  • Articles
  • Published:
Science China Chemistry Aims and scope Submit manuscript

Abstract

Inhibitory effect on tumor necrosis factor-α (TNF-α) production by sinomenine derivatives with embedment of small drug-like nitrogen hetereocyclic moieties has been studied in this work. Several new sinomenine derivatives having chlorophenyl substituent have been found to exhibit much more potent TNF-α inhibitory activity than natural sinomenine and other derivatives.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wermuth CG. The Practice of Medicinal Chemistry, 2nd ed. San Diego: Academic Press. 2003

    Google Scholar 

  2. Keller TH, Pichota A, Yin Z. A practical view of ‘ruggability’. Curr Opin Chem Biol, 2006, 10: 357–361

    Article  CAS  Google Scholar 

  3. Knorr L, Horlein H. Über ein neues chlorokodid. XVI. Mitteilung: Zur kenntnis des morphins von Ludwig Knorr. Chem Ber, 1907, 40: 4883–4889

    Article  Google Scholar 

  4. Wang Y, Fang Y, Huang W, Zhou X, Wang M, Zhong B, Peng D. Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats. J Ethnopharmacol, 2005, 98: 37–43

    Article  CAS  Google Scholar 

  5. Zhao Y, Li J, Yu KQ, Liu Y, Chen XG. Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B. Int J Immunopharmacol, 2007, 7: 637–645

    Article  CAS  Google Scholar 

  6. Ou, YQ, Chen LH, Li, XJ, Lin ZB, Li WD. Sinomenine influences capacity for invasion and migration in activated human monocytic THP-1 cells by inhibiting the expression of MMP-2, MMP-9, and CD147. Acta Pharm Sinica, 2009, 30: 435–441

    Article  CAS  Google Scholar 

  7. Previous modifications on sinomenine, see: Wu F, Feng X, Wu K, Cheng G, Huang Y, Ye X, Qiu P, Zheng X. Sinomenine structure-modified compound and its preparation method. CN1876634-A, 2007

  8. Luo J, Zeng H, Li Y, Yin S. 1-Substituted amine methyl diversine derivative and its preparation method. CN1948291-A, 2007

  9. Whittall J, Mather P. New 1,7-dibromodihydrocodeinone dimethylketal and its derivatives useful in the manufacture of a medicament for the treatment or prophylaxis of pain. WO2004022564-A3 (AU2003263301-A8), 2004

  10. Qin G, Tang X, Wang R, Zhou T, Lestage P, Caignard D, Renard P. New sinomenine derivatives useful for treatment of deficiencies of memory associated with cerebral aging and with neurodegenerative diseases. WO2004048340-A1 (CN1504469-A), 2004

  11. Yakida A, Sukegawa Y. Intestinal disorder preventative and treating agent-comprises Stephania plant-derived alkaloid, useful for treating e.g. enteritis, Crohn’s disease etc. JP8301778-A, 1997

  12. Ibuka T, Kitano M. Studies on the alkaloids of Menispermaceous plants. CCXXXIX. Synthesis of hasubanan derivative from sinomenine. Chem Pharm Bull, 1967, 15: 1944–1947

    Article  CAS  Google Scholar 

  13. Shionogi & Co. Ltd. Purification of morphinan derivatives. JP64021845-B, 1966

  14. Shionogi & Co. Ltd., 6-Methylenemorphinan derivatives. JP65010153-B, 1966

  15. Shionogi & Co. Ltd., 6,7-Dihydroxymorphinan derivatives. JP65010217-B, 1966

  16. Wu F, Zheng X, Qiu P, Qiu S. Sinomenine salt compound and its preparation method. CN1995019-A, 2008

  17. Pan Y, Li Y, Bu Q, Huang L, Wang J, Li J. 17-Sulfonyl sinomenine, has potential medicinal application prospect providing structure formula, preparation method and concrete steps. CN1785977-A, 2006

  18. Pan Y, Li Y, Bu Q, Huang L, Wang J, Li J. N-Alkyl sinomenine has potential medicinal application prospect. CN1785976-A, 2006

  19. Christians U, Kaever VW. New compound N-demethyl-sinomenine. WO9942105-A (US6372756-B1), 1999

  20. Tang Q, Luo J, Zhu Q, Li Y, Yin S. Synthesis and anti-inflammatory activities investigation of sinomenine derivatives on ring C. Nat Prod Res, 2006, 20: 1015–1023

    Article  CAS  Google Scholar 

  21. Yao ZJ, Zhou HB. Derivative of sinomenine with pyrazine cycle being connected to C cycle, its synthetic method and application. CN1687065-A (ZL 200510024478.9), 2006

  22. Yao ZJ, Zhou HB. Sinomenine derivative with C cycle connected to five-membered heterocycle and its preparation. CN1687070-A (ZL 200510024479. 3), 2006

  23. Lou YT, Zhou HB, Zou J, Yan LC, Bi EG, Sun B, Yao ZJ. Modification of poorly bioactive sinomenine into more potent immunosuppressive agents by embedding of drug-like fragments. Tetrahedron Lett, 2010, 51: 485–488

    Article  CAS  Google Scholar 

  24. Yan LC, Bi EG, Lou YT, Wu XD, Liu ZD, Zou J, Wang Y, Ma Z, Lin GM, Sun SH, Bian C, Chen AZ, Yao ZJ, Sun B. Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis. Biochem. Biophys Res Comm, 2010, 391: 1093–1098

    Article  CAS  Google Scholar 

  25. Smolen JS, Steiner G. Therapeutic strategies for rheumatoid arthritis. Nat Rev Drug Discov, 2003, 2, 473–488

    Article  CAS  Google Scholar 

  26. Ye XR, Yan KX, Wu KM, Feng XZ, Huang YM, Qiu P. Synthesis and anti-inflammatory analgesic activities of sinomenine derivatives. Acta Pharm Sinica, 2004, 39, 180–183

    CAS  Google Scholar 

  27. Iijima I, Minamikawa J, Jacobson AE, Rice KC. Studies in the (+)-morphinan series. 4. A markedly improved synthesis of (+)-morphine. J Org Chem, 1978, 43: 1462–1463

    Article  CAS  Google Scholar 

  28. Qin GW, Tang XC, Wang R, Zhou TX, Lestage P, Caignard DH, Renard P. New sinomenine derivatives useful for treatment of deficiencies of memory associated with cerebral aging and with neurodegenerative diseases. WO2004048340, 2004

  29. Fleischhacker W, Viebock F, Zeidler F. Strukturund konfigurationsbeweis für das diketon aus 14-bromcodeinon. Monatsh. Chem, 1970, 101: 1215–1222

    Article  CAS  Google Scholar 

  30. Breedveld FC. Antagonisten van tumornecrosisfactor: Infliximab, adalimumab en etanercept. Ned Tijdschr Geneeskd, 2005, 149: 2273–2277

    CAS  Google Scholar 

  31. Manthey CL, Wang SW, Kinney SD, Yao Z. SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukocyte Biol, 1998, 64: 409–417

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Bing Sun or ZhuJun Yao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, M., Ma, L., Lou, Y. et al. Sinomenine derivatives with embedment of nitrogen-containing heterocycles exhibiting potent TNF-αinhibitory activity. Sci. China Chem. 55, 2537–2547 (2012). https://doi.org/10.1007/s11426-012-4588-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11426-012-4588-8

Keywords

Navigation